首页> 外文OA文献 >Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

【2h】

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

机译：同种异体造血干细胞移植前两种氟达拉滨的减少强度调理方案的比较：Fludarabine / Melphalan与急性移植物与宿主疾病的发病率较高，非复发性死亡率以及较低的复发发病率超过Fludarabine / Busulfan

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A Shimoni; I Hardan; N Shem-Tov; A Rand; C Herscovici; R Yerushalmi; A Nagler;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine|[sol]|melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine|[sol]|busulfan [J] . A Shimoni, I Hardan, N Shem-Tov, Leukemia . 2007,第10期

机译：同种异体造血干细胞移植前两种基于氟达拉滨的低强度调理方案的比较：氟达拉滨| [sol] |美法仑与急性移植物抗宿主病发病率高，非复发死亡率和复发率低相关氟达拉滨| [sol] |白消安
2. Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. [J] . Bertz H, Illerhaus G, Veelken H, Annals of oncology: official journal of the European Society for Medical Oncology . 2002,第1期

机译：复发或难治性淋巴瘤患者的同种异体造血干细胞移植：大剂量常规治疗与氟达拉滨为基础的低强度治疗方案的比较。
3. Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR [J] . Nath Rajneesh, Zhou Zheng, Cerny Jan, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：减少强度调理（RIC）方案造血细胞移植（HCT）用于急性髓性白血病（AML）：从CibMTR中的氟氮滨/伯氟烷（FB）和氟氨拉滨/脲醛（FM）的方案进行比较
4. Fludarabine Phosphete and Melphalan - An Immunosuppressive Reduced Intensity Conditioning (RIC) Regimen for AUogeneic Stem Cell Transplantation in Patients with a Range of Hematological Malignancies [C] . G. Jackson, C. Richardson, G. Morgan, European Haematology Association . 2002

机译：Fludarabine phospete和Melphalan - 一种免疫抑制性降低的强度调理（RIC）治疗患者血液学恶性肿瘤患者的促孕酮干细胞移植方案
5. Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia [O] . Vishal Dhere, Scott Edelman, Edmund K. Waller, -1

机译：急性骨髓性白血病患者同种异体的白消安/ cytoxan调理与强度降低的氟达拉滨/美法仑调理在异基因造血干细胞移植中的应用
6. More Intensive Fludarabine/Busulfan (Flu/Bu) Conditioning Regimens Result in Similar Outcomes Without Adding Serious Toxicity When Compared to Fludarabine/Melphalan (Flu/Mel) in Patients Undergoing Allogeneic Hematopoietic Cell Transplant (Allo-HCT) [O] . Jeremy Pappacena, Valkal Bhatt, Gunjan L. Shah, 2018

机译：更加强烈的氟纳比林/母艇（Flu / Bu）调理方案导致类似的结果，而不是在接受同种异体造血细胞移植（Allo-Hct）的血糖胺/ Melphalan（Flu / Mel）时添加严重毒性

著录项

引文网络

相似文献

相关主题

期刊订阅